Jun Nakata¹, Yoshiki Nakae², Yo Mizutani³, Manabu Kawakami², Soyoko Morimoto⁴, Hiroko Nakajima⁵, Fumihiro Fujiki⁴, Sumiyuki Nishida⁶, Naoki Hosen⁷, Akihiro Tsuboi⁴, Yusuke Oji⁸, Yoshihiro Oka⁷, Haruo Sugiyama⁵ (1.Biomedical Infromatics, Osaka University, Osaka, Japan, 2.Hematol., Nissei Hospital, Tokyo, Japan, 3.Ikeda Municipal Hospital, Osaka, Japan, 4.Cancer Immunotherapy, Osaka University, Osaka, Japan, 5.Cancer Immunology, Osaka University, Osaka, Japan, 6.Respiratory Medicine and Clinical Immunology, Osaka University, Osaka, Japan, 7.Cancer Stem Cell Biology, Osaka University, Osaka, Japan, 8.Functional Diagnostic Science, Osaka University, Osaka, Japan)

Yanhua Wang, Shotaro Hagiwara, Hiroshi Kazama, Kana Iwatare, Aya Watanabe, Yuki Iizuka, Norina Tanaka, Masayuki Shiseki, Junji Tanaka (Dept. Hematology, Tokyo Women's Med. Univ., Tokyo, Japan)

Tatsuya Suwabe¹, Yasuhiko Shibasaki², Hiroyuki Sato³, Suguru Tamura¹, Takayuki Katagiri¹, Kyoko Fuse¹, Hirohito Sone¹, Miwako Narita³, Masayoshi Masuko² (1.Hematology, Endocrinology and Metabolism, Niigata Univ., Niigata, Japan, 2.Hematopoietic Cell Transplant., Niigata Univ. Med. Dent. Hospital, Niigata, Japan, 3.Labo. of Hematol. Oncol., Health Sci., Niigata Univ., Niigata, Japan)

Junichiro Yuda^1,2,3, Kohta Itahashi², Takuma Irie², Nobuhiko Yamauchi^1,3, Yumi Osada^1,2, Yosuke Togashi², Yosuke Minami¹, Hiroyoshi Nishikawa² (1.National Cancer Center Hospital East, Department of Hematology, 2.Division of Cancer Immunology, National Cancer Center, 3.National Cancer Center Hospital East, Department Experimental Therapeutics)

Lisa Hirose¹, Hiroshi Kohara¹, Miyako Sagara¹, Yoshie Miura¹, Yasuki Hijikata¹, Yasushi Soda¹, Shohei Miyamoto¹, Satoshi Takahashi¹, Masaru Shinozaki¹, Tamami Denda¹, Yukihisa Tanaka¹, Yasunori Ota¹, Eri Watanabe¹, Toru Tanaka², Motoo Nakajima², Sachiko Kiniwa³, Ryuhei Okuyama³, Hideo Fukuhara⁴, Keiji Inoue⁴, Tsutomu Namikawa⁴, Kazuhiro Hanazaki⁴, Kenzaburo Tani¹ (1.The Institute of Medical Science, Tokyo Univ., Tokyo, Japan, 2.SBI Pharmaceuticals Co. Ltd., Tokyo, Japan, 3.School of Medicine, Shinshu University, Nagano, Japan, 4.Kochi Medical School, Kochi University, Kochi, Japan)

Ryo Ishino^1,2, Yumi Kawase¹, Toshio Kitawaki¹, Naoshi Sugimoto^2,3, Yasushi Ino⁴, Tomoki Todo⁴, Akifumi Takaori¹, Norimitsu Kadowaki² (1.Department of Hematology and Oncology, Kyoto University, Kyoto, Japan, 2.Division of Hematology, Rheumatology and Respiratory, Kagawa University, Kagawa, Japan, 3.CiRA, Kyoto University, Kyoto, Japan, 4.Division of Innovative Cancer Therapy, IMSUT, Tokyo, Japan)